Insider screener

Period: 12 months Type of trade: Sold × Plan: Not on a plan × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,362 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,362 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,362 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,362 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,362 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,362 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,362 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Mar 2026
Mark A. Morais Chief Operating Officer
Sold at will
$16.63K 1,804 at 9.22
2.5%
Not planned
16 Mar 2026
Christopher C. Swenson Chief Legal Officer
Sold at will
$16.53K 18,366 at 0.90
0.9%
Not planned
16 Mar 2026
Arjun Agarwal Senior Vice President, Finance
Sold at will
$16.31K 395 at 41.30
2.1%
Not planned
16 Mar 2026
Edward J Zecchini See Remarks
Sold at will
$16.11K 2,014 at 8.00
1.8%
Not planned
16 Mar 2026
Haitao Cui Executive Vice President
Sold at will
$15.71K 3,888 at 4.04
2.8%
Not planned
16 Mar 2026
Rabourn Amy Zaremba Head of Fin. Quality Assurance
Sold at will
$14.77K 2,816 at 5.25
1.5%
Not planned
16 Mar 2026
Husnal Shah Chief Product Officer
Sold at will
$13.60K 3,651 at 3.73
17.9%
Not planned
16 Mar 2026
Sarah A. Mussetter Chief Legal Officer
Sold at will
$12.96K 4,037 at 3.21
3.5%
Not planned
16 Mar 2026
Benjamin Machinas Beneski SVP, Chief Technical Officer
Sold at will
$11.94K 4,835 at 2.47
2.4%
Not planned
16 Mar 2026
Sold at will
$10.59K 2,832 at 3.74
4.6%
Not planned
16 Mar 2026
Greg Foley Chief Executive Officer
Sold at will
$10.28K 2,584 at 3.98
13.4%
Not planned
16 Mar 2026
Aaron Deykin Chief Medical Officer
Sold at will
$8.31K 894 at 9.29
2.7%
Not planned
16 Mar 2026
Sold at will
$8.09K 9,700 at 0.83
1.4%
Not planned
16 Mar 2026
Michael Gray CFO and COO
Sold at will
$7.92K 852 at 9.29
2.8%
Not planned
16 Mar 2026
Robert E. Harris Chief Accounting Officer
Sold at will
$7.58K 665 at 11.40
7.4%
Not planned
16 Mar 2026
Adam Houghton Chief Business Officer
Sold at will
$6.49K 699 at 9.29
2.8%
Not planned
16 Mar 2026
Steven P. Coen See remarks
Sold at will
$4.77K 708 at 6.74
7.2%
Not planned
16 Mar 2026
Eugene Nonko Director · indirect
Sold at will
$4.58K 458 at 10.00
0.0%
Not planned
16 Mar 2026
Jesse Griffith Chief Operations Officer
Sold at will
$4.50K 1,402 at 3.21
3.2%
Not planned
16 Mar 2026
Allison Ambrose General Counsel
Sold at will
$4.41K 475 at 9.29
2.8%
Not planned
16 Mar 2026
Joseph Walter Vazzano Chief Financial Officer
Sold at will
$3.74K 785 at 4.76
0.1%
Not planned
16 Mar 2026
Jennifer Stevens Chief Regulatory Officer
Sold at will
$3.19K 774 at 4.12
0.6%
Not planned
16 Mar 2026
Bryan F. Cox Chief of Research
Sold at will
$2.39K 579 at 4.12
0.4%
Not planned
16 Mar 2026
Richard Marshak Chief Commercial Officer
Sold at will
$1.73K 419 at 4.12
0.4%
Not planned
16 Mar 2026
Jodi Devlin Chief of Clinical Operations
Sold at will
$1.12K 273 at 4.12
0.3%
Not planned
16 Mar 2026
Michael E Maroone Director · indirect
Sold at will
$621.52 2 at 310.76
0.8%
Not planned
13 Mar 2026
Sold at will
$16.45M 380,000 at 43.30
1.5%
Not planned
13 Mar 2026
Eduardo Vivas Director
Sold at will
$9.59M 20,910 at 458.67
0.3%
Not planned
13 Mar 2026
Patrizio Vinciarelli Chairman and CEO
Sold at will 11×
$8.54M 50,000 at 170.86
0.5%
Not planned
13 Mar 2026
W Anthony Will Director
Sold at will 2×
$6.94M 53,026 at 130.83
49.1%
Not planned
13 Mar 2026
Thurman J Rodgers Director · indirect
Sold at will
$5.99M 137,250 at 43.61
7.9%
Not planned
13 Mar 2026
Caroline Cochran Co-Founder, COO · indirect also filed by Jacob DeWitte
Sold at will
$4.38M 72,960 at 60.00
8.8%
Not planned
13 Mar 2026
Richard Craig Bealmear Chief Financial Officer
Sold at will
$4.33M 72,090 at 60.00
15.7%
Not planned
13 Mar 2026
Andrew D Lundquist Senior Vice President
Sold at will
$4.13M 34,500 at 119.68
66.4%
Sold half or more
13 Mar 2026
Sold at will
$4.09M 80,776 at 50.64
29.7%
Not planned
13 Mar 2026
Matt Zmigrosky EVP, Chief Legal and Admin Off
Sold at will
$3.76M 20,899 at 180.00
25.7%
Not planned
13 Mar 2026
Scott Lish Chief Operating Officer
Sold at will
$3.20M 260,535 at 12.30
24.2%
Not planned
13 Mar 2026
Caroline Cochran Co-Founder, COO also filed by Jacob DeWitte
Sold at will
$2.69M 44,828 at 60.00
5.9%
Not planned
13 Mar 2026
Christopher M Cuddy Senior Vice President
Sold at will
$2.57M 35,000 at 73.50
9.6%
Not planned
13 Mar 2026
Ian R Pinner Senior Vice President
Sold at will
$2.44M 34,106 at 71.53
27.3%
Not planned
13 Mar 2026
Morris S Young CEO · indirect
Sold at will
$1.94M 37,905 at 51.13
1.6%
Not planned
13 Mar 2026
Reuven Yeganeh Director · indirect
Sold at will
$1.85M 370,000 at 5.00
100%
Sold half or more
13 Mar 2026
Thomas R Donahue VP, CFO & Treasurer
Sold at will
$1.71M 30,000 at 57.10
4.8%
Not planned
13 Mar 2026
Clint D Coghill Director · indirect
Sold at will
$1.71M 256,232 at 6.66
7.3%
Not planned
13 Mar 2026
Dmitriy Dorosh Principal Accounting Officer
Sold at will 2×
$1.41M 3,109 at 453.42
2.7%
Not planned
13 Mar 2026
Rajeev Saggar Chief Medical Officer
Sold at will
$1.28M 35,365 at 36.30
16.9%
Not planned
13 Mar 2026
Joshua Jergensen President & COO
Sold at will
$1.25M 36,335 at 34.28
1.3%
Not planned
13 Mar 2026
Joseph D Margolis Chief Executive Officer · indirect
Sold at will
$1.07M 7,500 at 142.08
10.1%
Not planned
Showing 14,301–14,350 of 23,362. ← Newer Page 287 of 468 Older →